Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
Brain and Behavior in Dystonia: A Multicenter Study
(GAC 0062)
Protocol ID
03.02.079G
Protocol Description
The purpose of this study is to measure different types of brain function in patients with movement disorders such as dystonia. We will also measure brain function in those who carry the dystonia gene but do not have symptoms of the disease, as well as healthy volunteers who do not carry the gene.
Eligibility Criteria
Patients with dystonia
Primary Investigator(s)
- David Eidelberg, MD
Contact Information
Last Update
December 9, 2009How did I get to this page?
Related Information
-
News Room
- North Shore-LIJ Celebrates Inauguration of Florence & Robert A. Rosen Family Wellness Center—a Free Behavioral Health Treatment Program for Law Enforcement and Military Personnel and their Families
- Feinstein Researchers Develop New Genetic Method and Identify Novel Genes for Schizophrenia
- Second Annual Brain Aneurysm Awareness Walk to be Held Oct. 2 at Jones Beach
-
Clinical Trials
- Movement Disorders - Functional Correlates Study (08-191)
- Breast Cancer - Clinical Trial, Combination Therapy (06-083)
- Breast Cancer - Clinical Trial, Combination Therapy (08-164)
- Chronic Lymphocytic Leukemia - Blood Cell Study (04-057/G)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Genetic Correlates of Memory Impairment (03.04.169T)
- Cognitive Aging: Screening and Genetic Associations (07-127)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Biomarkers of Rheumatic Diseases (02-159G)
- Tissue Donation Program - Breast Tissue Collection (04-031T)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- Research Recruitment Screening Database (05.08.167T)
- Research Recruitment Screening Database (05-067)
- Tissue Donation Program - Synovial Tissue Collection (05-054)
- Epilepsy - Genetic Marker and Enzyme Study (07.08.009)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Alzheimer's Disease - Endocannabinoid System Study (05.04.140)
- Chronic Lymphocytic Leukemia - Genetic Study (04-054/G)
- Schizophrenia - Functional MRI of Medication Effects (02.04.030)
- Diamond Blackfan Anemia Registry (01.10.088G)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Epilepsy - Multicenter Study (06.08.058)
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Parkinson's Disease Genetics Database (07-057)
- The CALGB Leukemia Tissue Bank (01.08.141)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Respiratory Papillomatosis - Celebrex Study (03.02.131)
- Brain Tumor - Tissue Donation Study (06-086)
- Parkinson’s Disease - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern Analysis
- Metastatic Brain Tumor Study (08-10-24)
- Glioblastoma - Clinical Trial (08-06-234)
- Schizophrenia - Genetic Study (08-252)
- Brain and Behavior in Dystonia Study (08-283)
- B-Cell Study (08-337)
- Huntington's Disease - Clinical Trial (09-012)
- Genetics and Dimensions of Psychopathology (09-062)
- Memory Disorders Study (08-219)
- Women with Epilepsy - Pregnancy Outcomes and Deliveries - WEPOD
- Parkinson’s Disease - Microvascular Changes in Parkinson’s Disease: Relationship to Levodopa-Induced Dyskinesia
- Parkinson’s Disease - Metabolic Networks and the Cognitive Treatment Response in Parkinson’s Disease
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
-
Neurosciences
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment and at Six Month Follow-up (11-196A)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
- Brain and Behavior in Dystonia Study (08-283)
- Brain AVM - Clinical Trial (06.02.063)
- Brain Networks in Parkinson's Disease (04-113T)
- Cannabis - Dopamine Study - (09-002)
- Clinical Correlates of Memory Impairment (03.08.160)
- Dementia - Clinical Trial (08-295)
- Dystonia - Deep Brain Stimulation Study (06-109T)
- Epilepsy
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Epilepsy - Genetic Marker and Enzyme Study (07.08.009)
- Epilepsy - Multicenter Study (06.08.058)
- Glioblastoma - Clinical Trial (08-06-234)
- Huntington's Disease - Clinical Trial (09-012)
- Huntington's Disease - Coenzyme Q10 Study (07-124)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Memory Disorders Study (08-219)
- Metastatic Brain Tumor Study (08-10-24)
- MIF - Spinal Cord Injury Study (09-026)
- Movement Disorders - Functional Correlates Study (08-191)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Neuroendocrine Tumors - Imaging Study (03-117)
- Parkinson's Disease Genetics Database (07-057)
- Parkinson's Disease - Genetic Study (07-058)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Parkinson's Disease - Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel (B09-004)
- Parkinson’s Disease - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern Analysis
- Parkinson’s Disease - Efficacy, Safety, and Tolerability of Pioglitazone
- Parkinson’s Disease - Efficacy, Safety and Tolerability of CoganeTM (B10-046)
- Parkinson’s Disease - Efficacy and Safety of Sufinamide (B10-026)
- Parkinson’s Disease - Efficacy and Safety Study of Low and High Doses of Safinamide (10-02-48-031)
- Parkinson’s Disease - Metabolic Networks and the Cognitive Treatment Response in Parkinson’s Disease
- Parkinson’s Disease - Microvascular Changes in Parkinson’s Disease: Relationship to Levodopa-Induced Dyskinesia
- Parkinson’s Disease - Open-Label Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel (B10-039)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Schizophrenia-like Effects of Cannibinoids (09-157)
- Swallowing Therapy Study (07-130)
- Web-delivery Treatment for Substance Abuse (10-016A)
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health